Agenda - Thursday, September 24

Showing 1 of 1 Streams

Business Forum

8:30am - 8:35am

Chair Remarks

8:35am - 8:50am

Innovation Presentation: Pioneering taRNA Therapies for Infectious Disease and Beyond

Cory Sago - CEO, Amplitude Therapeutics

8:50am - 9:05am

Innovation Presentation: Pioneering brain-specific delivery of antibody-oligo conjugates to treat neurological diseases

David Hardwicke - Co-Founder, Aerska

9:05am - 9:20am

Innovation Presentation: Exploring First-In-Class Re-Dosable circRNA For Rare Metabolic Disease

Bakhytar Ali - CEO, Amirxa Pharma

9:20am - 9:35am

Innovation Presentation Opportunity Available

Please contact Jennifer Wickett for more information: Jennifer.Wickett@informa.com

9:35am - 9:50am

Innovation Presentation Opportunity Available

Please contact Jennifer Wickett for more information: Jennifer.Wickett@informa.com

9:50am - 10:15am

Innovation Presentation Opportunity Available

Please contact Jennifer Wickett for more information: Jennifer.Wickett@informa.com

Showing 1 of 1 Streams

Business Forum

11:00am - 12:55pm

Investor Insights: Question Circle

An open Q&A session offering attendees the opportunity to engage directly with leading investors, gain insights into funding strategies, market trends, and what drives investment decisions in the RNA therapeutics space.

Soyoung Park - General Partner, 1004 Venture Partners

Showing 1 of 1 Streams

Business Forum

2:10pm - 3:10pm

Pharma Insights Question Circle

An open Q&A session providing attendees the chance to interact with pharma leaders, explore industry perspectives, and discuss strategies for advancing RNA therapeutics from discovery to commercialization.

Elena Diez Cecilia - Senior Director External Innovation DPDS, Johnson & Johnson
Shaan Gandhi - VP and Head of Partnerships, PAVE, Pfizer

Thursday, September 24Thursday, 24 September 2026 - EST (Eastern Time, UTC-05:00

Get the Latest Event Updates